These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1003867)

  • 1. Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.
    Brecht HM; Banthien F; Schoeppe W
    Klin Wochenschr; 1976 Nov; 54(22):1095-105. PubMed ID: 1003867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma noradrenaline concentrations in essential hypertension and their decrease after long-term treatment with a beta-receptor-blocking agent (prindolol).
    Brecht HM; Banthien F; Ernst W; Schoeppe W
    Clin Sci Mol Med Suppl; 1976 Dec; 3():485S-488S. PubMed ID: 1071667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind factorial trial of prindolol and hydrochlorothiazide in hypertension.
    Chalmers JP; Korner PI; Tiller DJ; Bune AJ; Steiner JD; West MJ; Wing LM; Uther JF
    Med J Aust; 1976 May; 1(18):650-3. PubMed ID: 781495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of prindolol on plasma noradrenaline, plasma renin and sodium-potassium metabolism in patients with essential hypertension.
    Brecht HM; Werner E; Schoeppe W
    Adv Clin Pharmacol; 1976; 11():66-9. PubMed ID: 1032572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged clonidine treatment: catecholamines, renin activity and aldosterone following exercise in hypertensives.
    Manhem P; Hökfelt B
    Acta Med Scand; 1981; 209(4):253-60. PubMed ID: 7015796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Telemetry of blood pressure in healthy subjects and patients with tachycardia and hypertension under Prindolol treatment].
    Bachour G; Bender F; Wessels F; Losse H
    Med Klin; 1976 Apr; 71(14):580-5. PubMed ID: 1264004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of total body potassium and decrease of exchangeable sodium after long-term treatment with a beta-receptor-blocking agent (prindolol) in essential hypertension.
    Brecht HM; Werner E; Schoeppe W
    Clin Sci Mol Med Suppl; 1976 Dec; 3():551s-554s. PubMed ID: 1071679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma noradrenaline concentration and pressor response to infused noradrenaline in patients with borderline hypertension, and mild or moderate essential hypertension.
    Iimura O; Kikuchi K; Sato S
    Jpn Circ J; 1984 Feb; 48(2):159-67. PubMed ID: 6700112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pindolol and methyldopa on blood pressure and plasma norepinephrine.
    Winer N; Carter CH; Eddy H
    Am Heart J; 1982 Aug; 104(2 Pt 2):425-31. PubMed ID: 7048879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute and chronic effects of nitrendipine on plasma catecholamines in hypertensive patients.
    el-Beheiry H; Ruedy N; Wall RA; Murphy M; Wright JM
    Can J Cardiol; 1993; 9(1):41-6. PubMed ID: 8439828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.
    Kralberg BE; Tolagen K
    Am J Med; 1976 May; 60(6):891-6. PubMed ID: 14504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.
    Schoeppe W; Brecht HM
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6994788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure, heart rate, and plasma catecholamines in normal and hypertensive children and their siblings at rest and after standing.
    McCrory WW; Klein AA; Rosenthal RA
    Hypertension; 1982; 4(4):507-13. PubMed ID: 7152630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of prindolol on the blood-pressure profile of hypertensives (with special consideration of response to exercise and plasma-renin activity) (author's transl)].
    Dufey K; Krönig B; Fries G; Gunkel R; Walter U; Wolff HP
    Dtsch Med Wochenschr; 1975 Aug; 100(35):1726-30. PubMed ID: 1157670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of the beta-receptor-blocker prindolol on renal hypertension (author's transl)].
    Undeutsch K; Sieberth HG; Meurer KA
    Klin Wochenschr; 1976 Nov; 54(22):1077-84. PubMed ID: 1003866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension: the effect of atenolol (author's transl)].
    Philipp T; Cordes U; Distler A
    Dtsch Med Wochenschr; 1977 Apr; 102(15):569-74. PubMed ID: 14816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
    Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
    Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in plasma renin activity and blood pressure after acute and chronic administration of beta-adrenergic receptor-blocking drugs.
    Morgan T; Carney S; Roberts R
    Clin Sci Mol Med Suppl; 1975 Jun; 2():81s-83s. PubMed ID: 802647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma noradrenaline and blood pressure in hypothyroid patients: effect of gradual thyroxine treatment.
    Manhem P; Hallengren B; Hansson BG
    Clin Endocrinol (Oxf); 1984 Jun; 20(6):701-7. PubMed ID: 6467635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.